Simultaneous estimation of S(-) amlodipine besylate hemipentahydrate and losartan potassium in combined dosage form by using UV-spectroscopy

Der Pharmacia Lettre

Volumn 4, Issue 3, 2012, Pages 897-905

  Singh, Sunil ^a   Patel, Kuldeep ^b   Agrawal, Vipin Ku ^a   Chaturvedi, Shashank ^a  

^a Invertis Group of Institutions   (India)

^b NRI Institute of Pharmacy   (India)

Author keywords

Derivative spectroscopy; Method development; Validation

Indexed keywords

AMLODIPINE BESYLATE; LOSARTAN POTASSIUM; METHANOL;

ABSORPTION SPECTROPHOTOMETRY; ACCURACY; ANALYTIC METHOD; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG DETERMINATION; DRUG STRUCTURE; PHASE SEPARATION; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SOLVENT EXTRACTION; SPECTRAL SENSITIVITY; STRUCTURE ANALYSIS; TABLET FORMULATION; ULTRAVIOLET SPECTROSCOPY; VALIDATION PROCESS;

EID: 84864020114     PISSN: None     EISSN: 09755071     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Polinko M, Riffel K, Song H, Lo MW. J Pharma and Biomed Anal. 2003; 33: 73- 84.
2. Williams RC, Alasandro MS, Fasone VL, Boucher RJ, Edwards JF. J Pharma Biomed Anal. 1996; 14 (11): 1539-1546.
3. Mccarthy KE, Qingxi W, Tsai EW, Gilbert RE, Ip DP, Brooks MA. J. Pharm Biomed Anal. 1998; 17: 671 677.
4. Maurer HH, Kraemer T, Arlt JW. Ther. Drug Monit. 1998; 20: 706-713.
5. Furtek CI, Lo MW. J. Chroma: Biomed Appli. 1992; 573 (2): 295-301.
6. Lee H, Shim HO, Lee HS. Chromatographia.1996; 42: 39-42.
7. Walily AFME, Belal SF, Heaba EA. J Pharma Biomed Anal.1997; 15 (7): 1021-1029.
8. Farthing D, Sica D, Fakhry I, Pedro A, Gehr TWB. J Chromatogr B 1997; 704: 374-378.
9. Soldner A, Spahn-Langguth H, Mutschler E. J Pharma Biomed Anal. 1998; 16 (5):863-873.
10. Soldner A, Spahn-Langguth H, Palm D, Mutschler E. J Pharma Biomed Anal. 1998;17 (1): 111-124.
11. Dubey R, Vidhya k. Bhusari VK, Dhaneshwar SR. Scholar Research Library, DerPharmacia Lettre. 2011;3(2):334-342.
12. Argekar AP, Powar SG. J. Pharm. Biomed. Anal. 2000; 21: 1137-1142.
13. Rajamanickam V, Rathinaraj B, Thangavelpanian N, Pandian AR. Scholar Research Library, Der Pharmacia Lettre. 2010;2(4):40-46.
14. Halker UP, Bhandari NP, Rane SH. Indian Drugs. 1988; 35: 168.
15. Shimooka K, Sawada Y, Tatematsu H. J. Pharm. Biomed. Anal. 1989; 7: 1267.
16. Yeung PKF, Mosher SJ, Pollack PT. J. Pharm. Biomed. Anal. 1991; 9: 565.
17. Patki RV, Tamhanker CP, Tipnis HP. Indian Drugs. 1994; 31: 560.
18. Josefsson M, Zackrisson AL, Norlander B. J. Chromatogr. B; Biomed. Appl. 1995; 672; 310.
19. Shang F, Shang K. ZhoggnoYiyao Gangye Zazhi. 1996; 27: 411.
20. European Pharmacopoeia, 3rd ed. Council of Europe, Strasbourg, 2001: 431.
21. Avadhanulu AB, Srinivas JS, Anjaneyulu Y. Indian Drugs. 1996; 33: 36.
22. Sankar SR, Nanjan MJ, Vasudevan M. Ind J. Pharm. Sci. 1997; 59: 171.
23. Dhorda VJ, Shetkar NB. Indian Drugs. 1999; 36: 638.
24. Chandrashekhar TG, Rao PSN, Smrita K. J. Planar. Chromatogr. Mod. TLC. 1994;7: 458.
25. Pandya KK, Satia M, Gandhi TP. J. Chromatogr. B; Biomed. Appl. 1995; 667: 315.
26. Ilango K, Kumar PB, Prasad RV. Indian J. Pharm. Sci. 1997; 59: 336.
27. Agrekar AP, Powar SG. J. Pharm. Biomed. Anal. 2000; 21: 1137.
28. Bresford AP, Marcrac PV, Stopher DA. J. Chromatogr. 1987; 420: 178.
29. Feng Y, Meng Q, Guo X. Guandong Yaoxueyuan Xuebao. 1998; 14 (111): 118.
30. Yasuda T, Tanaka M, Iba K. J.Mass Spectrom. 1996; 31: 879.
31. Mohamed YE, Naglaa MEK, Bahia AM, Nasshwa GM. Bull. Fac. Pharm.1998;36:1.
32. Prasad CVN, Parihar C, Chowdhary TRS. Pharm. Pharmacol. Commun. 1998;4:325.
33. Prasad CVN, Saha RN, Parimoo P. Pharm. Pharmacol. Commun. 1999; 5: 383.
34. Sunil S, Dubey N, Jain DK. Asian J. Research Chem. 2010; 3(4):885-887.
35. Jain HK, Agrawal RK. Indian Drugs. 2000; 37: 196.
36. Mashru CR, Parikh PP. East. Pharm. 2000; 43: 111.
37. Khopade SA, Jain NK. Indian drugs. 2000; 37: 351.
38. Shukla R, Shivkumar R, Shivan KN.. Bull. Pharm. Res. 2011;1(1):62-6.
39. Topale PR Gaikwad NJ Tajane MR. Indian drugs. 2003; 40 (2): 119-121.